Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Milestone Pharmaceuticals Inc. | mist-20201231ex3215669c4.htm |
| 10-K - 10-K - Milestone Pharmaceuticals Inc. | mist-20201231x10k.htm |
| EX-31.2 - EX-31.2 - Milestone Pharmaceuticals Inc. | mist-20201231ex312e890cd.htm |
| EX-31.1 - EX-31.1 - Milestone Pharmaceuticals Inc. | mist-20201231ex311521d3a.htm |
| EX-4.3 - EX-4.3 - Milestone Pharmaceuticals Inc. | mist-20201231ex43fbf7399.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-231347 and 333-236971) of Milestone Pharmaceuticals Inc. of our report dated March 29, 2021 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Montréal, Québec, Canada
March 29, 2021